av/acasti-pharma--big.svg

TSX:ACST

Acasti Pharma Inc.

  • Stock

Last Close

2.80

26/07 20:00

Market Cap

28.86M

Beta: 1.22

Volume Today

10.80K

Avg: 4.98K

  • market

    STOCKS
  • ipo date

    Feb 07, 2012

Acasti Pharma Inc., a biopharmaceutical company, engages in the development and commercialization of pharmaceutical products for cardiovascular diseases. It is evaluating strategic partnerships for the clinical development of CaPre. The company was incorporated in 2002 and is headquartered in Laval, Canada.

peer of

Earnings

Earnings per Share (Estimate*)

-4-222014-07-152016-07-112018-08-142020-08-132022-06-21

Revenue (Estimate*)

2M4M6M8M2014-07-152016-07-112018-08-142020-08-132022-06-21

*Estimate based on analyst consensus